T‐Cell Receptor Repertoire in Tumor‐Infiltrating Lymphocytes. Analysis of Melanoma‐Specific Long‐Term Lines

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Immunotherapy with Emphasis on Tumor Immunology

• Publication date

  1994-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00002371-199408000-00002PMID 7804531
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oligoclonal expansion of Vβ8+ cells in interleukin-2-activated T cells residing in subcutaneous metastatic melanoma

  2004cited by this paper
• T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines.

  1994cited by this paper
• T cell receptor V beta gene usage in allograft-derived cell lines analyzed by a polymerase chain reaction technique.

  1992cited by this paper
• Analysis of T-cell receptor alpha/beta variability in lymphocytes infiltrating a melanoma metastasis.

  1992cited by this paper
• Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas.

  1992cited by this paper
• Evidence for selective accumulation of intrathyroidal T lymphocytes in human autoimmune thyroid disease based on T cell receptor V gene usage.

  1992cited by this paper
• Tumor eradication by adoptive transfer of cytotoxic T lymphocytes.

  1992cited by this paper
• Dominant rearrangements among human tumor‐infiltrating lymphocytes. Analysis of T‐cells derived from 32 patients with melanoma, lung, and renal cell carcinoma

  1992cited by this paper
• Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer.

  1992cited by this paper
• PCR-based analysis of the T-cell receptor V beta multigene family: experimental parameters affecting its validity.

  1992cited by this paper
• Tumor-infiltrating lymphocytes. Potential and limitations to their use for cancer therapy.

  1992cited by this paper
• Specificity and T cell receptor β chain usage of a human collagen type II‐reactive T cell clone derived from a healthy individual

  1992cited by this paper
• Evidence for the effects of a superantigen in rheumatoid arthritis.

  1991cited by this paper
• Analysis of T cell receptor beta and gamma genes from peripheral blood, regional lymph node and tumor-infiltrating lymphocyte clones from melanoma patients.

  1991cited by this paper
• Mouse Hepa-1 tumor is rejected by H-2Db-restricted CTL despite decreased MHC class I antigen expression.

  1991cited by this paper
• Abnormal T cell expansion and V-gene usage in myasthenia gravis patients

  1991cited by this paper
• Limited heterogeneity of rearranged T-cell receptor V α transcripts in brains of multiple sclerosis patients

  1991cited by this paper
• Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide.

  1991cited by this paper
• CD4+ T cell clones specific for the human p97 melanoma-associated antigen can eradicate pulmonary metastases from a murine tumor expressing the p97 antigen.

  1991cited by this paper
• Analysis of T cell receptor V alpha and V beta gene usage in synovia of patients with rheumatoid arthritis.

  1991cited by this paper
• Direct sequencing from low-melt agarose with Sequenase.

  1990cited by this paper
• Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomas.

  1990cited by this paper
• T cell receptor V beta gene usage in a human alloreactive response. Shared structural features among HLA-B27-specific T cell clones

  1990cited by this paper
• T cell antigen receptor V gene usage. Increases in V beta 8+ T cells in Crohn's disease.

  1990cited by this paper
• Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor V beta-specific antibodies

  1990cited by this paper
• Unique murine tumor-associated antigens identified by tumor infiltrating lymphocytes.

  1990cited by this paper
• Predominant expression of T cell receptor V alpha 7 in tumor-infiltrating lymphocytes of uveal melanoma.

  1990cited by this paper
• Long-term survival of adoptively transferred tumor-infiltrating lymphocytes in mice.

  1990cited by this paper
• In vivo distribution of adoptively transferred indium-111-labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanoma.

  1989cited by this paper
• Interaction of Staphylococcus aureus toxin "superantigens" with human T cells.

  1989cited by this paper
• Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes.

  1989cited by this paper
• Tumor-specific cytolysis by lymphocytes infiltrating human melanomas.

  1989cited by this paper
• T-cell receptor V alpha and C alpha alleles associated with multiple and myasthenia gravis.

  1989cited by this paper
• Adoptive immunotherapy of syngeneic murine leukemia is enhanced by the combination of recombinant IFN-gamma and a tumor-specific cytotoxic T cell clone.

  1988cited by this paper
• Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.

  1988cited by this paper
• Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study.

  1988cited by this paper
• Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention.

  1988cited by this paper
• Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.

  1987cited by this paper
• Protective immunity to progressive tumors can be induced by antigen presented on regressor tumors.

  1987cited by this paper
• Therapy of murine leukemia with cyclophosphamide and immune Lyt-2+ cells: cytolytic T cells can mediate eradication of disseminated leukemia.

  1986cited by this paper
• T-cell receptor variable region gene usage in T-cell populations.

  1986cited by this paper
• Adoptive immunotherapy of a syngeneic murine leukemia with a tumor-specific cytotoxic T cell clone and recombinant human interleukin 2: correlation with clonal IL 2 receptor expression.

  1986cited by this paper
• Studies on chemically induced rat tumors. II. Partial protection against syngeneic lethal tumors by cloned syngeneic cytotoxic T lymphocytes

  1983cited by this paper
• A simple and very efficient method for generating cDNA libraries.

  1983cited by this paper
• Protection against syngeneic lymphoma by a long-lived cytotoxic T-cell clone.

  1982cited by this paper
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

  1979cited by this paper
• Immunogenicity of tumor antigens.

  1977cited by this paper

• Tumor-Infiltrating Lymphocytes, CAR-, and T-Cell Receptor-Modified T Cells in Solid Cancer Oncology

  2025cites this paper
• Human cancer germline antigen-specific cytotoxic T cell—what can we learn from patient

  2020cites this paper
• The Adaptome as Biomarker for Assessing Cancer Immunity and Immunotherapy.

  2020cites this paper
• Melanoma antigens and related immunological markers.

  2017cites this paper
• T-cell receptor-engineered T cells for cancer treatment: current status and future directions

  2017cites this paper
• Influence of Antigen Receptor Avidity, Affinity, and Specificity on Genetically Engineered T Cells

  2015cites this paper
• Récepteurs des lymphocytes t, matières correspondantes et procédés d'utilisation

  2010cites this paper
• Transduction of Human T Cells with a Novel T-Cell Receptor Confers Anti-HCV Reactivity

  2010influential citation
• Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognition

  2009cites this paper
• Structural basis for the recognition of mutant self by a tumor-specific, MHC class II–restricted T cell receptor

  2007cites this paper
• Characterization of T-cell repertoire in hairy cell leukemia patients before and after recombinant immunotoxin BL22 therapy

  2006cites this paper
• Identification of a hepatitis C virus–reactive T cell receptor that does not require CD8 for target cell recognition

  2006cites this paper
• Recognize the Same Tumor Epitope Utilizing Distinct T-Cell Receptor Variable and Joining Regions Identification of MART-1-specific T-Cell Receptors : T Cells

  2006cites this paper
• T-cell Receptor Repertoire in Matched MARTi Peptide-. stimulated Peripheral Blood Lymphocytes and Tumor-infiltrating Lymphocytes

  2006cites this paper
• TCRBV 14 in HLA-A 2-matched Primary Human Melanomas-Chain Variable Region β Overexpression of the T-Cell Receptor Updated

  2006cites this paper
• Protein mimicry of DNA and pathway regulation.

  2005cites this paper
• Antigen recognition and T-cell biology.

  2005cites this paper
• T cell avidity and tumor recognition: implications and therapeutic strategies

  2005cites this paper
• T cell receptor usage in malignant diseases

  2004cites this paper
• CD8-Independent Tumor Cell Recognition Is a Property of the T Cell Receptor and Not the T Cell 1

  2003cites this paper
• Adoptive Transfer of Cloned Melanoma-Reactive T Lymphocytes for the Treatment of Patients with Metastatic Melanoma

  2001cites this paper
• Tetramer-Guided Analysis of TCR β-Chain Usage Reveals a Large Repertoire of Melan-A-Specific CD8+ T Cells in Melanoma Patients1

  2000cites this paper
• Specific cytolytic T-cell responses to human CEA from patients immunized with recombinant avipox-CEA vaccine.

  2000cites this paper
• Tumorigenicity and immunogenicity of murine tumor cells expressing an MHC class II molecule with a covalently bound antigenic peptide.

  2000cites this paper
• T Cells in Melanoma + Melan-A-Specific CD8 Usage Reveals a Large Repertoire of -Chain b Tetramer-Guided Analysis of TCR

  2000cites this paper
• Quantitation of T-Cell Receptor Frequencies by Competitive Polymerase Chain Reaction: Dynamics of T-Cell Clonotype Frequencies in an Expanding Tumor-Infiltrating Lymphocyte Culture

  2000cites this paper
• Recognition of a shared human prostate cancer-associated antigen by nonclassical MHC-restricted CD8+ T cells.

  1999cites this paper
• Construction and binding analysis of recombinant single-chain TCR derived from tumor-infiltrating lymphocytes and a cytotoxic T lymphocyte clone directed against MAGE-1.

  1999cites this paper
• MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyte.

  1999cites this paper
• Quantitation of T-cell receptor frequencies by competitive PCR: generation and evaluation of novel TCR subfamily and clone specific competitors.

  1999cites this paper
• T Cells + MHC-Restricted CD8 Cancer-Associated Antigen by Nonclassical Recognition of a Shared Human Prostate

  1999cites this paper
• Monitoring Antitumour Immune Response During Immunotherapy of Cancer

  1999cites this paper
• Monoclonal TCR mRNA transcripts are preferentially detected in the TCR variable alpha chain in CD8(+) T-lymphocytes: implications for immunomonitoring.

  1999cites this paper
• T Cell‐Receptor V Gene Use by CD4+ Melanoma‐Reactive Clonal and Oligoclonal T‐Cell Lines

  1998cites this paper
• Context of HLA-A 31 andA 33 Tyrosinase-Related Protein-2 by CTL in the Recognition of an Antigenic Peptide Derived from Alessandro Sette

  1998cites this paper
• Recognition of an antigenic peptide derived from tyrosinase-related protein-2 by CTL in the context of HLA-A31 and -A33.

  1998cites this paper
• A 15-Year Follow-up of AJCC Stage III Malignant Melanoma Patients Treated Postsurgically with Newcastle Disease Virus (NDV) Oncolysate and Determination of Alterations in the CD8 T Cell Repertoire

  1998cites this paper
• Oligoclonal T cells in human cancer

  1998cites this paper
• A 15-YearFollow-up ofAJCC StageIII Malignant MelanomaPatients Treated Postsurgically withNewcastle Disease Virus (NDV)Oncolysate andDetermination of Alterations intheCD8 T CellRepertoire

  1998cites this paper
• Mart1 is located on mouse chromosome 19 and is excluded as a candidate for ep and ru

  1997cites this paper
• The repertoire of T cell antigen receptor beta-chain variable regions associated with psoriasis vulgaris.

  1997cites this paper
• Monitoring of Cancer Patients Undergoing Active or Passive Immunotherapy

  1997cites this paper
• T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.

  1997cites this paper
• Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen.

  1997cites this paper
• Identification of a T-cell receptor from a therapeutic murine T-cell clone.

  1997cites this paper
• Lisa A. DeBruyne Alfred E. Chang Mark J. Cameron Zhi-yong Yang David Gordon Elizabeth G. Nabel

  1996cites this paper
• Direct transfer of a foreign MHC gene into human melanoma alters T cell receptor Vβ usage by tumor-infiltrating lymphocytes

  1996cites this paper
• The immunotherapy of solid cancers based on cloning the genes encoding tumor-rejection antigens.

  1996cites this paper
• Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses.

  1995cites this paper
• Overexpression of the T-cell receptor beta-chain variable region TCRBV14 in HLA-A2-matched primary human melanomas.

  1995cites this paper
• Characterization of the functional specificity of a cloned T-cell receptor heterodimer recognizing the MART-1 melanoma antigen.

  1995cites this paper
• Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope.

  1994cites this paper